Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.
Cutler C, Kim HT, Bindra B, Sarantopoulos S, Ho VT, Chen YB, Rosenblatt J, McDonough S, Watanaboonyongcharoen P, Armand P, Koreth J, Glotzbecker B, Alyea E, Blazar BR, Soiffer RJ, Ritz J, Antin JH. Cutler C, et al. Among authors: glotzbecker b. Blood. 2013 Aug 22;122(8):1510-7. doi: 10.1182/blood-2013-04-495895. Epub 2013 Jul 16. Blood. 2013. PMID: 23861248 Free PMC article. Clinical Trial.
Immunomodulatory effects of vitamin D: implications for GVHD.
Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D. Rosenblatt J, et al. Among authors: glotzbecker b. Bone Marrow Transplant. 2010 Sep;45(9):1463-8. doi: 10.1038/bmt.2009.366. Epub 2010 Jan 18. Bone Marrow Transplant. 2010. PMID: 20081878 Free PMC article.
PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.
Rosenblatt J, Glotzbecker B, Mills H, Vasir B, Tzachanis D, Levine JD, Joyce RM, Wellenstein K, Keefe W, Schickler M, Rotem-Yehudar R, Kufe D, Avigan D. Rosenblatt J, et al. Among authors: glotzbecker b. J Immunother. 2011 Jun;34(5):409-18. doi: 10.1097/CJI.0b013e31821ca6ce. J Immunother. 2011. PMID: 21577144 Free PMC article.
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions.
Richardson PG, Ho VT, Cutler C, Glotzbecker B, Antin JH, Soiffer R. Richardson PG, et al. Among authors: glotzbecker b. Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S88-90. doi: 10.1016/j.bbmt.2012.10.023. Epub 2012 Oct 23. Biol Blood Marrow Transplant. 2013. PMID: 23089567 Free article. No abstract available.
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.
Nikiforow S, Kim HT, Bindra B, McDonough S, Glotzbecker B, Armand P, Koreth J, Ho VT, Alyea EP 3rd, Blazar BR, Ritz J, Soiffer RJ, Antin JH, Cutler CS. Nikiforow S, et al. Among authors: glotzbecker b. Biol Blood Marrow Transplant. 2013 May;19(5):804-11. doi: 10.1016/j.bbmt.2013.02.009. Epub 2013 Feb 14. Biol Blood Marrow Transplant. 2013. PMID: 23416855 Free PMC article. Clinical Trial.
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Brunner AM, Kim HT, Coughlin E, Alyea EP 3rd, Armand P, Ballen KK, Cutler C, Dey BR, Glotzbecker B, Koreth J, McAfee SL, Spitzer TR, Soiffer RJ, Antin JH, Ho VT, Chen YB. Brunner AM, et al. Among authors: glotzbecker b. Biol Blood Marrow Transplant. 2013 Sep;19(9):1374-80. doi: 10.1016/j.bbmt.2013.06.008. Epub 2013 Jun 18. Biol Blood Marrow Transplant. 2013. PMID: 23791626 Free article.
42 results